|
|
||||||||
From the Departments of Neurology (Dr. Crino and R. White) and Neurosurgery (Drs. Duhaime and Baltuch), and the Penn Epilepsy Center (Drs. Crino and Baltuch), University of Pennsylvania School of Medicine; and the Childrens Hospital of Philadelphia (Dr. Duhaime), PA.
Address correspondence and reprint requests to Dr. Peter B. Crino, Department of Neurology, University of Pennsylvania, 3 West Gates Building, 3400 Spruce Street, Philadelphia, PA 19104; e-mail: crinop{at}mail.med.upenn.edu
OBJECTIVE: Focal cortical dysplasia is characterized by disorganized cortical lamination, dysplastic and heterotopic neurons, and an association with epilepsy. The contribution that dysplastic and heterotopic neurons make to epileptogenesis in focal cortical dysplasia is unknown and the phenotype of these cells may be distinct. The authors hypothesized that the expression of genes encoding glutamatergic (glutamate [GluR] and N-methyl-D-aspartate NMDA receptors [NR]) and
-aminobutyric acid A receptor (GABAAR) subunits is distinct in dysplastic and heterotopic neurons and that changes in receptor gene expression could be defined in a cell-specific pattern.
METHODS: Single immunohistochemically labeled dysplastic and heterotopic neurons were microdissected from human focal cortical dysplasia specimens obtained during epilepsy surgery. Pyramidal neurons were microdissected from postmortem control cortex and from temporal cortex without dysplasia resected during temporal lobectomy. Poly (A) messenger RNA (mRNA) from single neurons was amplified, radiolabeled, and used to probe complementary DNA (cDNA) arrays containing GluR16, NR1A,1B, NR2AD, and GABAAR
16, and -Rß13 subunit cDNAs. The relative hybridization intensities of each mRNA-cDNA hybrid were quantified by phosphorimaging.
RESULTS: GluR, NR, and GABAAR subunit mRNA expression did not differ between control neurons and nondysplastic epilepsy specimens. Expression of GluR4, NR2B, and NR2C subunit mRNA was increased, and NR2A and GABAARß1 subunit mRNA was decreased in dysplastic compared with pyramidal and heterotopic neurons. In contrast, GABAAR
1, -R
2, and -Rß2 as well as GluR1 mRNA levels were reduced in both dysplastic and heterotopic neurons.
CONCLUSIONS: Differential expression of GluR, NR, and GABAAR mRNA in dysplastic and heterotopic neurons demonstrates cell specific gene transcription changes in focal cortical dysplasia. These results suggest that dysplastic and heterotopic neurons may be pharmacologically distinct and make differential contributions epileptogenesis in focal cortical dysplasia.
This article has been cited by other articles:
![]() |
Y. Ben-Ari, J.-L. Gaiarsa, R. Tyzio, and R. Khazipov GABA: A Pioneer Transmitter That Excites Immature Neurons and Generates Primitive Oscillations Physiol Rev, October 1, 2007; 87(4): 1215 - 1284. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xiang, H.-X. Chen, X.-X. Yu, M. A. King, and S. N. Roper Reduced Excitatory Drive in Interneurons in an Animal Model of Cortical Dysplasia J Neurophysiol, August 1, 2006; 96(2): 569 - 578. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Calcagnotto, M. F. Paredes, T. Tihan, N. M. Barbaro, and S. C. Baraban Dysfunction of Synaptic Inhibition in Epilepsy Associated with Focal Cortical Dysplasia J. Neurosci., October 19, 2005; 25(42): 9649 - 9657. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Calcagnotto and S. C. Baraban Prolonged NMDA-Mediated Responses, Altered Ifenprodil Sensitivity, and Epileptiform-Like Events in the Malformed Hippocampus of Methylazoxymethanol Exposed Rats J Neurophysiol, July 1, 2005; 94(1): 153 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Alonso-Nanclares, R. Garbelli, R. G. Sola, J. Pastor, L. Tassi, R. Spreafico, and J. DeFelipe Microanatomy of the dysplastic neocortex from epileptic patients Brain, January 1, 2005; 128(1): 158 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Andre, J. Flores-Hernandez, C. Cepeda, A. J. Starling, S. Nguyen, M. K. Lobo, H. V. Vinters, M. S. Levine, and G. W. Mathern NMDA Receptor Alterations in Neurons from Pediatric Cortical Dysplasia Tissue Cereb Cortex, June 1, 2004; 14(6): 634 - 646. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Najm, Z. Ying, T. Babb, P. B. Crino, R. Macdonald, G. W. Mathern, and R. Spreafico Mechanisms of epileptogenicity in cortical dysplasias Neurology, March 23, 2004; 62(6_suppl_3): S9 - S13. [Abstract] [Full Text] |
||||
![]() |
L. Tassi, N. Colombo, R. Garbelli, S. Francione, G. Lo Russo, R. Mai, F. Cardinale, M. Cossu, A. Ferrario, C. Galli, et al. Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome Brain, August 1, 2002; 125(8): 1719 - 1732. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Porter, A. Brooks-Kayal, and J. A. Golden Disorders of Cortical Development and Epilepsy Arch Neurol, March 1, 2002; 59(3): 361 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Roesler, R. L. D. Machado, J. Quevedo, and P. B. Crino Differential expression of glutamate and GABA-A receptor subunit mRNA in cortical dysplasia Neurology, December 26, 2001; 57(12): 2325 - 2326. [Full Text] [PDF] |
||||
Read all Correspondence
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |